Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
GT Apeiron Therapeutics logo

GT Apeiron Therapeutics

Recent Finacing

Equity

Recent Raise

$27M

GT Apeiron Therapeutics is a Shanghai biotech combining AI-driven and traditional drug discovery workflows, collaborating with Exscientia to advance oncology targets from hit identification through preclinical and clinical development.

Founded 2019
Shanghai, China
11-50
Private
apeiron-bio.com

Highlights

Focus Areas

Artificial Intelligence (AI)
Biotechnology
Health Care
Therapeutics

Recent Investors

GT Healthcare Capital Partners logo

Financials

$27M

Total Raised

1

Funding round

1

Investor


Team

Upgrade to view the team

See the team members at GT Apeiron Therapeutics.